Statistics

Total Visits

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study79

Select a period of time:

Number of views in the range

Views
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study33

Views

Views
July 202518
August 20250
September 20256
October 20250
November 20255
December 20254
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
Brazil8
United Kingdom5
Argentina2
Canada1
Chile1
Ethiopia1
Kenya1
Mexico1
Netherlands1
 

Top cities views

Views
Amsterdam1
Awasa1
Camaquã1
Canoas1
Careaçu1
Ciudad del Este1
Concepción1
Contagem1
Dallas1
Edinburgh1